What Researchers Did
Researchers conducted a prospective, randomized, controlled study with 50 diabetic ulcer patients to evaluate hyperbaric oxygen therapy (HBOT) efficacy using the Bates-Jensen Wound Assessment Tool.
What They Found
The hyperbaric oxygen therapy (HBOT) group demonstrated a significantly better healing recovery rate, with a Bates-Jensen Wound Assessment Tool score change of 14.28 ± 2.24, compared to 7.28 ± 1.84 in the control group. Additionally, the HBOT group had a significantly shorter mean hospital stay (14.28 ± 2.24 days) compared to the control group (21.28 ± 2.24 days).
What This Means for Canadian Patients
For Canadian patients with diabetic ulcers, hyperbaric oxygen therapy (HBOT) could serve as an effective additional treatment to promote wound healing. This therapy may also help reduce the duration of hospital stays, potentially improving patient quality of life and healthcare resource utilization.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A potential limitation of this study is its relatively small sample size of 50 patients, which may affect the generalizability of the findings.